Bridgeway Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,100
| Closed | -$46.9K | – | 1357 |
|
|
2023
Q3 | $46.9K | Hold |
13,100
| – | – | ﹤0.01% | 1310 |
|
|
2023
Q2 | $48.3K | Sell |
13,100
-1,580,000
| -99% | -$5.83M | ﹤0.01% | 1333 |
|
|
2023
Q1 | $5.27M | Sell |
1,593,100
-1,046,000
| -40% | -$3.46M | 0.14% | 239 |
|
|
2022
Q4 | $10.2M | Buy |
2,639,100
+188,800
| +8% | +$733K | 0.27% | 77 |
|
|
2022
Q3 | $5.95M | Buy |
2,450,300
+2,187,200
| +831% | +$5.31M | 0.16% | 210 |
|
|
2022
Q2 | $521K | Hold |
263,100
| – | – | 0.01% | 867 |
|
|
2022
Q1 | $481K | Buy |
263,100
+250,000
| +1,908% | +$457K | 0.01% | 947 |
|
|
2021
Q4 | $18K | Sell |
13,100
-250,000
| -95% | -$344K | ﹤0.01% | 1255 |
|
|
2021
Q3 | $297K | Sell |
263,100
-100,000
| -28% | -$113K | 0.01% | 1160 |
|
|
2021
Q2 | $581K | Sell |
363,100
-180,000
| -33% | -$288K | 0.01% | 1023 |
|
|
2021
Q1 | $956K | Buy |
+543,100
| New | +$956K | 0.02% | 879 |
|